January 21 – 24, 2009
The Westin San Diego Hotel
San Diego, California
Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI
Owen N. Witte, University of California, Los Angeles, CA
Bruce R. Zetter, Children’s Hospital, Harvard Medical School, Boston, MA
Prostate cancer remains a leading cause of cancer death worldwide. A fundamental understanding of the nature of the genetic changes which initiate and progress this malignancy is critical to defining new approaches for therapy. Changes within the epithelium, its surrounding stromal environment, and at distant sites of metastasis must be identified and understood in relationship to cancer progression and therapeutic response or failure.
This AACR Special Conference presented an international group of experts in basic and clinical aspects of prostate cancer research and essential new technologies needed to attack this important problem. The major goal of the conference was to foster an open framework in which to discuss our current state of knowledge of prostate cancer fundamental biology, diagnostic strategies, and therapeutic modalities and define the next phase of basic and translational research necessary to improve treatment options.
The conference attracted more than 200 attendees from around the world, with over half of the attendees presenting posters of their latest research efforts. In addition to the plenary and poster sessions, the program also included a keynote address by Dr. Charles L. Sawyers of the Memorial Sloan-Kettering Cancer Center and a special forum on Biomarkers Beyond PSA presented by the National Cancer Institute's Early Detection Research Network (NCI-EDRN).
* Adobe Acrobat Reader required
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.